Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors.

Alam, Naufil;Cortina-Borja, Mario;Goetghebuer, Tessa;Marczynska, Magdalena;Brichard, Bénédicte;et.al.
(2012) Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology —

Files

BodyfatabnormalityinHIV-infe.bin
  • Open Access
  • Unknown
  • 664.3 KB
Download
pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 244.85 KB
Request a copy

Details

Authors
  • Alam, Naufil
    Author
  • Cortina-Borja, Mario
    Author
  • Goetghebuer, Tessa
    Author
  • Marczynska, Magdalena
    Author
  • Brichard, BénédicteUCLouvain
    Collaborator
Show more
Abstract
Fat abnormality was prevalent in close to half of children and adolescents, who had accumulated long treatment durations. Risk of fat abnormality was associated with specific drugs, including stavudine and ritonavir, and other variables. Our results underline the importance of continued surveillance of children treated with antiretroviral therapy.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Alam, N., Cortina-Borja, M., Goetghebuer, T., Marczynska, M., Vigano, A., & Thorne, C. (2012). Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. https://doi.org/10.1097/QAI.0b013e31824330cb